Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-06 Sale | 2026-10-08 4:07 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 4,522 | $31.68 | $143,273 | 554,703 (Indirect Direct) | View |
| 2026-09-30 Sale | 2026-10-01 4:30 pm | Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operating Officer | 10,000 | $33.19 | $331,856 | 139,914 (Direct) | View |
| 2026-09-23 Sale | 2026-09-24 4:05 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 2,210 | $39.17 | $86,565 | 559,225 (Indirect Direct) | View |
| 2026-09-08 Sale | 2026-09-09 4:05 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 8,210 | $45.61 | $374,498 | 561,435 (Indirect Direct) | View |
| 2026-08-25 Sale | 2026-08-26 4:05 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 18,921 | $49.57 | $937,957 | 569,645 (Indirect Direct) | View |
| 2026-08-24 Sale | 2026-08-26 4:00 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 50,160 | $50.47 | $2,531,582 | 195,862 (Direct) | View |
| 2026-08-19 Sale | 2026-08-20 4:09 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 404 | $49.9 | $20,160 | 246,022 (Direct) | View |
| 2026-08-10 Sale | 2026-08-12 4:35 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 51,499 | $47.25 | $2,433,176 | 588,566 (Indirect Direct) | View |
| 2026-07-27 Sale | 2026-07-29 4:05 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 2,210 | $42.11 | $93,061 | 640,065 (Indirect Direct) | View |
| 2026-07-14 Sale | 2026-07-15 4:15 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 8,210 | $40 | $328,437 | 642,275 (Indirect Direct) | View |
| 2026-06-30 Sale | 2026-07-01 4:10 pm | Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operating Officer | 10,000 | $41.58 | $415,798 | 149,914 (Direct) | View |
| 2026-06-29 Sale | 2026-07-01 4:05 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 8,220 | $39.83 | $327,398 | 650,485 (Indirect Direct) | View |
| 2026-05-26 Sale | 2026-05-28 4:15 pm | Rapport Therapeutics Inc. | RAPP | Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC 10% Owner | 18,572 | $40.05 | $743,753 | 7,249,743 (Indirect Direct) | View |
| 2026-05-11 Sale | 2026-05-13 7:06 pm | Rapport Therapeutics Inc. | RAPP | Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC 10% Owner | 133,618 | $40.24 | $5,377,323 | 7,268,315 (Indirect Direct) | View |
| 2026-05-07 Sale | 2026-05-11 5:07 pm | Rapport Therapeutics Inc. | RAPP | Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC 10% Owner | 276,513 | $40.12 | $11,094,906 | 7,401,933 (Indirect Direct) | View |
| 2026-04-17 Sale | 2026-04-21 7:36 pm | Rapport Therapeutics Inc. | RAPP | Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC 10% Owner | 426,005 | $40.32 | $17,175,244 | 7,678,446 (Indirect Direct) | View |
| 2026-04-17 Sale | 2026-04-21 4:55 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 20,225 | $39.99 | $808,844 | 246,426 (Direct) | View |
| 2026-04-10 Sale | 2026-04-14 4:13 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 19,865 | $35.03 | $695,823 | 266,651 (Direct) | View |
| 2026-04-08 Sale | 2026-04-09 4:30 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 360 | $34.9 | $12,564 | 286,516 (Direct) | View |
| 2026-03-30 Sale | 2026-03-31 4:27 pm | Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operating Officer | 10,000 | $28.19 | $281,857 | 159,914 (Direct) | View |
| 2026-03-25 Sale | 2026-03-26 4:41 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 10,115 | $29.99 | $303,355 | 286,876 (Direct) | View |
| 2026-03-05 Sale | 2026-03-09 4:07 pm | Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operating Officer | 2,014 | $28.93 | $58,265 | 169,914 (Direct) | View |
| 2026-02-18 Sale | 2026-02-19 7:06 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 10,916 | $29.35 | $320,373 | 658,705 (Indirect Direct) | View |
| 2026-02-17 Sale | 2026-02-19 7:05 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $29.02 | $246,655 | 481,155 (Direct) | View |
| 2026-01-20 Sale | 2026-01-22 7:00 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 10,916 | $26.11 | $285,071 | 669,621 (Indirect Direct) | View |
| 2026-01-15 Sale | 2026-01-16 4:06 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $26.84 | $228,132 | 395,575 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-10 Option Award | 2026-06-10 5:57 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | MARAGANORE JOHN Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-10 5:52 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | PEREZ ROBERT J Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-10 5:46 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | PAUL STEVEN M Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-10 5:28 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | Silva Paul M Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-10 5:26 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | HEALY JAMES Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-10 5:25 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | Huber Reid M Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-10 5:24 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | Young Wendy B. Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-10 5:23 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | Sanchez Ramiro Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-02-19 Exercise | 2026-02-19 7:05 pm | N/A 2033-12-05 | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 6,000 | $0 | 481,155 (Direct) | View |
| 2026-02-19 Exercise | 2026-02-19 7:05 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 6,000 | $1.8 | 481,155 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:15 pm | N/A 2036-02-02 | Rapport Therapeutics Inc. | RAPP | Sevigny Jeffrey Chief Medical Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:14 pm | N/A 2036-02-02 | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 428,000 | $0 | 428,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:12 pm | N/A 2036-02-02 | Rapport Therapeutics Inc. | RAPP | Ignelzi Troy A. Chief Financial Officer | 148,000 | $0 | 148,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:11 pm | N/A 2036-02-02 | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:09 pm | N/A 2036-02-02 | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 103,000 | $0 | 103,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:02 pm | N/A 2036-02-02 | Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operating Officer | 132,000 | $0 | 132,000 (Direct) | View |